Evidence map›Paper›PMID 34226835›Full record

ArticleISBT science series2021

A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.

Durba Biswas, Chikam Maiti, Biplabendu Talukder, Md Azharuddin, Sayantan Saha, Sumita Pandey, Arijit Das, Setu Das Adhikari, Yogiraj Ray, Biswanath S Sarkar and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in ISBT science series, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. COVID-19 Advanced Care.Journal of personalized medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Durba BiswasDepartment of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India.
Chikam MaitiDepartment of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India.
Biplabendu TalukderDepartment of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India.
Md AzharuddinDepartment of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India.
Sayantan SahaDepartment of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India.
Sumita PandeyDepartment of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India.
Arijit DasDepartment of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India.
Setu Das AdhikariDepartment of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India.
Yogiraj RayDepartment of Medicine I.D&B.G Hospital Kolkata India.
Biswanath S SarkarDepartment of Medicine I.D&B.G Hospital Kolkata India.
Sekhar R PaulDepartment of Medicine I.D&B.G Hospital Kolkata India.
Bibhuti SahaDepartment of Tropical Medicine Calcutta School of Tropical Medicine Kolkata India.
Sandip PaulCSIR-Indian Institute of Chemical Biology Kolkata India.
Shilpak ChatterjeeDepartment of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India.
Dipyaman GangulyCSIR-Indian Institute of Chemical Biology Kolkata India.
Prasun BhattacharyaDepartment of Immunohematology and Blood Transfusion Medical College and Hospital Kolkata India.ORCID https://orcid.org/0000-0002-1982-5227
Medical College and Hospital, Kolkata · INIndian Institute of Chemical Biology · INGD Hospital & Diabetes Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use of convalescent plasma has become increasingly popular worldwide. This study aimed to identify an appropriate strategy of donor recruitment and to evaluate the appropriateness of pre-set plasma donation guidelines. Material and Methods: In this prospective study conducted from May to September 2020, the donors were recruited under the following two circumstances: Group I, patients in the post-COVID-19 follow-up in the clinic, and Group II, patients recovered from COVID-19 recruited through mass and electronic media. A pre-set donor selection criteria and laboratory investigation was designed according to national and international guidelines. Approximately 500 ml of COVID-19 convalescent plasma (CCP) was collected from recovered individuals in each group by two different cell separators. The overall donor's attendance rate, deferral rate, adverse events and donor compliance was analysed and compared between the two groups. Results: There was a significant difference in attendance in relation to registration between the groups ( Conclusion: Recruitment of patients in the post-COVID-19 follow-up in the clinic was more effective than the general recruitment through mass and electronic media for convalescence plasma donation in a resource-constrained blood centre.

Indexed as

convalescent plasmadonor recruitmentplasmapheresis

Identifiers

PMID34226835
PMCPMC8242402
OpenAlexW3161840630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.